子宫内膜异位症与其他良性指征全子宫切除术后并发症特征的比较:一项NSQIP研究
基于美国外科医师学会国家手术质量改进项目2018至2019年数据库的回顾性队列研究,纳入29 742例18至55岁因良性指征行全子宫切除术的患者,其中3 596例(12.1%)指征为子宫内膜异位症。子宫内膜异位症组发生主要并发症(3.8% vs 3.4%;校正OR 1.25;P=0.033)和深部手术部位感染/器官腔隙感染(2.3% vs 1.6%;OR 1.42;P=0.024)的风险更高,接受输血的风险更低(1.8% vs 3.0%;OR 0.58;P<0.001),但主要并发症总体罕见。
要点
- 子宫内膜异位症组主要并发症发生率3.8%,其他良性指征组3.4%,校正OR 1.25(P=0.033)。
- 子宫内膜异位症组深部手术部位感染/器官腔隙感染发生率2.3%,其他组1.6%,OR 1.42(P=0.024)。
- 子宫内膜异位症组输血率1.8%,其他组3.0%,OR 0.58(P<0.001)。
核心结论
- 因子宫内膜异位症行全子宫切除术的患者更可能发生主要并发症和深部手术部位感染,但主要并发症总体罕见。
研究设计与样本
- 回顾性队列研究,数据来自2018至2019年美国外科医师学会国家手术质量改进项目数据库,纳入29 742例18至55岁因良性指征行全子宫切除术的患者,其中3 596例(12.1%)指征为子宫内膜异位症。
主要发现
- 子宫内膜异位症组主要并发症发生率3.8%,其他良性指征组3.4%,校正OR 1.25(P=0.033)。
- 子宫内膜异位症组深部手术部位感染/器官腔隙感染发生率2.3%,其他组1.6%,OR 1.42(P=0.024)。
- 子宫内膜异位症组输血率1.8%,其他组3.0%,OR 0.58(P<0.001)。
- 两组轻微并发症(5.8% vs 6.9%;P=0.874)和总体并发症(8.8% vs 9.4%;P=0.185)无差异,浅表手术部位感染、脓毒症、静脉血栓栓塞、再入院或再手术无差异,30天死亡2例,子宫内膜异位症组无死亡。
- 子宫内膜异位症组住院时间≥1天73.1% vs 其他组78.6%(P=0.983),手术时间中位数118.0 vs 125.0分钟(P<0.001)。
关键数值与推荐
- 校正模型协变量包括年龄、种族、族裔和手术路径。
- 子宫内膜异位症组更年轻、以白人为主、合并症更少,既往腹部手术、既往盆腔手术、腹腔镜路径和粘连松解比例更高(所有P<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: Compare the difference in postoperative morbidity for benign total hysterectomy by indication. DESIGN: Retrospective cohort. SETTING: United States hospitals participating in the American College of Surgeons National Surgical Quality Improvement Project database from 2018 to 2019. PATIENTS: Patients undergoing total hysterectomy for benign indications age 18 to 55 years old. INTERVENTIONS: Univariate comparisons were made between patients with hysterectomies for endometriosis and other benign indications. Unadjusted and adjusted logistic regression models were used to investigate the association between primary outcomes and hysterectomy indication; covariates in the adjusted model include age, race, ethnicity, and route. MEASUREMENTS AND MAIN RESULTS: A total of 29 742 women underwent hysterectomies, of which 3596 (12.1%) were performed for endometriosis. Patients undergoing hysterectomy for endometriosis were likely to be younger, were predominately White, and had less comorbidities. They were also more likely to have previous abdominal surgery, have previous pelvic surgery, undergo a laparoscopic approach, and undergo lysis of adhesions (all p <.001). Overall length of stay (≥1 day 73.1% vs 78.6%; p = .983) and operative time (median 118.0 vs 125.0 minutes; p <.001) were similar in both groups. Examining primary outcomes, patients with endometriosis were more likely to experience major morbidity (3.8% vs 3.4%; adjusted odds ratio [OR], 1.25; p = .033), with no difference in minor or overall morbidity (5.8% vs 6.9% [p = .874] and 8.8% vs 9.4% [p = .185], respectively). There were two 30-day mortalities, none in the endometriosis group. Patients with endometriosis were more likely to develop deep surgical site infection (SSI)/organ-space infection (2.3% vs 1.6%; OR, 1.42; p = .024) and less likely to receive blood transfusion (1.8% vs 3.0%; OR, 0.58; p <.001). There was no difference in occurrence of superficial SSI, sepsis, venous thromboembolism, readmission, or reoperation between groups. CONCLUSION: Patients undergoing hysterectomy for endometriosis were more likely to experience major morbidity and deep SSI, although overall major morbidity is rare.
引用
- Stewart KA, Tessier KM, Lebovic DI, et al. Comparing Characteristics of and Postoperative Morbidity after Hysterectomy for Endometriosis versus other Benign Indications: A NSQIP Study. J Minim Invasive Gynecol. 2022. PMID: 35472598. doi:10.1016/j.jmig.2022.04.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。